A Three-Part, Open-Label, Fixed-Sequence Study to Evaluate the Effect of Multiple Doses of Itraconazole, Phenytoin, and Paroxetine on the Single-Dose Pharmacokinetics of Poziotinib in Healthy Adult Subjects
Latest Information Update: 25 Sep 2021
At a glance
- Drugs Poziotinib (Primary) ; Itraconazole; Paroxetine; Phenytoin
- Indications Breast cancer; Colorectal cancer; Gastric cancer; Glioma; Head and neck cancer; Lung cancer; Non-small cell lung cancer; Solid tumours
- Focus Pharmacokinetics
- Sponsors Spectrum Pharmaceuticals
- 01 Sep 2021 Status changed from active, no longer recruiting to completed.
- 04 Aug 2021 New trial record